PROVIDER PROFILE · NPI 1679545412

Dana Bridges

MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
457
Beneficiaries
—
Total drug cost
$673K
Distinct drugs
15
Brand share
28.9%
Top prescribed drugs
Lacosamide57 claims
Everolimus44 claims
Levetiracetam43 claims
Cenobamate40 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
0.0
Cost
78.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.